{
  "report_rows": [
    {
      "kpi": "Non-GAAP diluted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$5.86 vs. cons $5.793; Day-1 residual -1%; 5-day residual -2%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Revenue",
      "prediction": "IN-LINE",
      "answer": "pred ~$1.595B vs. cons $1.580B; Day-1 residual -1%; 5-day residual -2%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Organic growth",
      "prediction": "BEAT",
      "answer": "pred ~4.4% vs. cons 4.0%; Day-1 residual -1%; 5-day residual -2%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Non-GAAP EPS (Q3 FY2026)",
      "prediction": "UNCHANGED",
      "answer": "guide ~$5.95 vs. cons $6.006; Day-1 residual -1%; 5-day residual -2%",
      "confidence": "LOW"
    },
    {
      "kpi": "Non-GAAP EPS (FY2026)",
      "prediction": "UNCHANGED",
      "answer": "guide ~$24.15 vs. cons $24.195; Day-1 residual -1%; 5-day residual -2%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Defense orders / book-to-bill (H2 FY2026)",
      "prediction": "BETTER",
      "answer": "guide above 1.0; no reliable numeric consensus; Day-1 residual -1%; 5-day residual -2%",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": -1.0,
  "day1_confidence": "LOW",
  "day5_residual_pct": -2.0,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "FOLLOW-THROUGH \u2014 limited forward-estimate upside",
  "day5_confidence": "LOW"
}